A Study of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus (T2DM)
Public ClinicalTrials.gov record NCT06660173. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Study to Evaluate the Efficacy, Safety & Tolerability of Maridebart Cafraglutide in Adults With T2DM
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The main purpose of this study is to assess the dose-response relationship of maridebart cafraglutide on glucose control compared with placebo.
Study identification
- NCT ID
- NCT06660173
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 409 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 7, 2024 (Actual)
- Primary completion
- Oct 6, 2025 (Actual)
- Completion
- Nov 10, 2026 (Estimated)
- Last update posted
- Sep 11, 2026
2024 – 2026
United States locations
- U.S. sites
- 28
- U.S. states
- 15
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Accel Research Site - Birmingham Clinical Research Unit | Birmingham | Alabama | 35216 | — |
| Anaheim Clinical Trials | Anaheim | California | 92801 | — |
| Hope Clinical Research LLC | Canoga Park | California | 91303 | — |
| Orange County Research Center | Lake Forest | California | 92630 | — |
| San Jose Clinical Trials | San Jose | California | 95128 | — |
| Northeast Research Institute - Neri | Fleming Island | Florida | 32003 | — |
| New Horizon Research Center | Miami | Florida | 33165 | — |
| Florida Institute for Clinical Research | Orlando | Florida | 32825 | — |
| Conquest Research - Winter Park | Winter Park | Florida | 32789 | — |
| Accel Research Site - Neurostudies | Decatur | Georgia | 30030 | — |
| Cedar Crosse Research and Health Care | Chicago | Illinois | 60607 | — |
| Tandem Clinical Research - Marrero | Marrero | Louisiana | 70072 | — |
| DM Clinical - Detroit | Southfield | Michigan | 48076 | — |
| Montana Medical Research | Missoula | Montana | 59808 | — |
| Physicians East | Greenville | North Carolina | 27834 | — |
| Diabetes and Endocrinology Associates of Stark County Inc | Canton | Ohio | 44718 | — |
| Alliance for Multispecialty Research | Norman | Oklahoma | 73069 | — |
| Trial Management Associates - Myrtle Beach | Myrtle Beach | South Carolina | 29572 | — |
| FutureSearch Trials of Neurology | Austin | Texas | 78731 | — |
| Velocity Clinical Research - Dallas | Dallas | Texas | 75230 | — |
| DM Clinical Research - Cyfair Clinical Research Center | Houston | Texas | 77065 | — |
| Southern Endocrinology Associates PA | Mesquite | Texas | 75149 | — |
| Be Well Clinical Studies | Round Rock | Texas | 78681 | — |
| Diabetes and Glandular Disease Clinic | San Antonio | Texas | 78229 | — |
| DM Clinical Research - Martin Diagnostic Clinic | Tomball | Texas | 77375 | — |
| Charlottesville Medical Research Center | Charlottesville | Virginia | 22911 | — |
| Manassas Clinical Research Center Inc | Manassas | Virginia | 20110 | — |
| Eastside Research Associates Health Research | Redmond | Washington | 98052 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 68 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06660173, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 11, 2026 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06660173 live on ClinicalTrials.gov.